Global FMD Disease Market

FMD Disease Market Size, Share, Growth Analysis, By Technique(Conventional Vaccines (Aluminum Hydroxide/Saponin-based Vaccines, Oil-based Vaccines), and Emergency Vaccines), By Animal Type(Cattle, Sheep and goat, Pigs, and Others (antelope), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35E2021 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 67 | Figures: 75

FMD Disease Market Insights

FMD Disease Market size was valued at USD 2.58 Billion in 2023 and is poised to grow from USD 2.79 Billion in 2024 to USD 5.21 Billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The global uptake of veterinary vaccines with emissions being elaborated to FMD vaccines has grown extensively because of the rising consumption of animal products accompanied by a higher population of animals. This can be attributed to the increasing appearance of livestock and zoonotic diseases in recent years due to factors including hostile environment modification, rapid globalization. These measures have contributed significantly to the veterinary vaccine market as governments of many countries across the globe focus on ensuring safe medical practices for a variety of animals, including communal and livestock. Laws governing the zoonotic organisms are in place both in developed and developing countries and this is because an outbreak of any one of them would have serious repercussions to a nation’s gross domestic products. Barrier deterrents consist of eliminating infected animals, and preserving appropriate inoculation transport reserves with modified strains.

The dynamic area of the animal sector due to increasing trend and demand in regard to milk, chicken egg meat and fabric through advanced and modern machinery has lured large investment. The FMD preventive measures like vaccination become crucial intervention for governments and private animal industry stakeholders because such disease outbreaks cost manifolds of financial capital. The absence of a final cure is so much more evident, made even more palpable by the numerous possible means of infection that can be used as arguments for the need to employ FMD vaccines.

Considering the substantial amount of livestock outputs that are contributed to the GDP of certain developing countries, animal healthcare practice is a much given attention. The development of new medications and vaccination facilities plays an important role in maintaining the cattle health realized by government organizations in these countries. But, on the other hand stringent measures and limitation of movement of animals or animal products through international borders in regions that are lavish regions such as North America and Europe have so substantially eliminated FMD outbreaks hence do not require these vaccines.

US FMD Disease Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

FMD Disease Market size was valued at USD 2.39 Billion in 2022 and is poised to grow from USD 2.58 Billion in 2023 to USD 4.82 Billion by 2031, at a CAGR of 8.1% during the forecast period (2024-2031).

The competitive landscape of the foot-and-mouth disease (FMD) market is highly fragmented, with several players operating in the market. The market is dominated by a few major players, including multinational pharmaceutical companies and vaccine manufacturers, as well as several regional and local players. The FMD market is expected to witness significant growth in the coming years, with a strong focus on research and development of advanced vaccines and therapeutics for the treatment and prevention of FMD. The market is likely to witness increased competition in the future, with a growing number of players entering the market and offering innovative products and services. 'MSD Animal Health', 'Zoetis', 'Boehringer Ingelheim', 'Bayer AG', 'Indian Immunologicals Ltd.', 'Biogenesis-Bago', 'Ceva Santé Animale', 'China Animal Husbandry Co., Ltd. (CAH)', 'Guangdong Dahuanong Animal Health Products Co., Ltd.', 'Heska Corporation', 'Indian Immunologicals Limited', 'Lanzhou Veterinary Research Institute', 'Limor de Colombia S.A.', 'Merial (Sanofi)', 'Minnesota Veterinary Diagnostic Laboratory', 'PVT-Polish Veterinary Pharmaceuticals Ltd.', 'RAKARB Veterinary Biotech.', 'Vecol S.A.', 'Vétoquinol', 'Bioveta a.s.'

The growing demand for animal protein and dairy products is a key driver of the FMD market, as FMD can cause significant losses in the livestock industry.

Increasing demand for FMD vaccines: The increasing demand for FMD vaccines, particularly in developing countries, is a key market trend. Governments around the world are taking initiatives to control and prevent FMD outbreaks, which is driving the demand for FMD vaccines.

Asia Pacific is anticipated to grow at a faster CAGR that is substantially higher throughout the projected period due to the increasing number of livestock animals, continued initiatives by market participants to commercialize veterinary vaccines, and increased investment in research and development in the region. In Africa, the Middle East, and Latin America, the vaccine for foot-and-mouth disease (FMD) is still in its infancy; nonetheless, it is projected that unmet vaccine demand will drive market expansion in these countries.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global FMD Disease Market

Report ID: SQMIG35E2021

$5,300
BUY NOW GET FREE SAMPLE